Information about breast density is an important part of breast cancer screening and ensuring early detection and treatment. That is why it will now be automatically included in a woman’s screening mammography report. Nova Scotia is the first province in Canada to use a software that assesses breast density and automatically shares results. “Breast health is a serious issue and it’s important to make sure
The Canadian Partnership Against Cancer (The Partnership) is leading vital work to create an action plan to eliminate cervical cancer in Canada. Your voice as a patient or member of the public helps define priorities for the future. Malatest, an independent research company, is working with the Partnership to lead a national survey to better understand Canadian attitudes and experiences to help improve cervical cancer
October is Breast Cancer Awareness Month, and the Canadian Cancer Survivor Network is focusing on creating a better future for patients, survivors and caregivers through education, connection and action. Here are some ways you can join CCSN in the Breast Cancer Awareness Month conversation: 1. Learn More About Breast Self Exams Self breast exams provide women an opportunity to check for abnormalities in their breast
Date: October 7, 2019 Our file number: 19-119291-196 The purpose of this Notice of Amendment is to notify about the additions of acalabrutinib, galcanezumab, larotrectinib, mannitol, neratinib, niraparib, ravulizumab, romosozumab, and sodium zirconium cyclosilicate to the Prescription Drug List (PDL) for human and veterinary use. These additions are effective at the time of posting. Rationale: A scientific review of these drugs against the criteria set out in
Were you or are you an early-stage breast cancer patient who lives in and accesses health care in Ontario? If so, the Canadian Cancer Survivor Network would like your input to help us with our Patient Evidence Submission to Health Quality Ontario (HQO) on Gene Expression Profiling (GEP) tests. CCSN is preparing a patient evidence submission on Gene Expression Profiling testing to HQO, which is
Clinical Trials Ontario (CTO) has been working with health charities and patient organizations like CCSN to build tools and resources about clinical trials that are informed by and meet the needs of their communities. CCSN is one of the organizations that has been engaged from the start of these efforts, and this update is intended to help you see what this collaborative work has produced.